China SXT Pharmaceuticals, Inc. (SXTC) |
| 1.66 0.1 (6.41%) 05-29 15:05 |
| Open: | 1.56 |
| High: | 1.72 |
| Low: | 1.56 |
| Volume: | 70,636 |
| Market Cap: | 1(M) |
| PE Ratio: | -0.03 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 2.14 |
| Resistance 1: | 1.86 |
| Pivot price: | 1.61 |
| Support 1: | 1.41 |
| Support 2: | 1.17 |
| 52w High: | 1047 |
| 52w Low: | 1.25 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
| EPS | -8340000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -12.500 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 11.7 |
| Return on Equity (ttm) | -18.3 |
Fri, 22 May 2026
SXTC Should I Buy - Intellectia AI
Fri, 22 May 2026
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
Mon, 04 May 2026
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
Thu, 09 Apr 2026
China SXT Pharmaceuticals announces $760,000 share offering on Monday - Investing.com
Mon, 23 Mar 2026
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
Fri, 30 Jan 2026
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |